{"id":{"repo_id":"utahstate","oai_identifier":"oai:digitalcommons.usu.edu:etd-6034"},"canonical_url":"https://search.ndltd.org/etd/utahstate/oai:digitalcommons.usu.edu:etd-6034","repository":{"repo_id":"utahstate","name":"Utah State University","base_url":"https://digitalcommons.usu.edu/do/oai/"},"display":{"title":"Amelioration of Chikungunya through Inhibition of the Inflammatory Response","abstract":"CHIK is an emerging viral disease that is rapidly spreading around the world and causing significant illness in infected people. This virus is spread through the bite of an infected mosquito. Symptoms of disease include high fever, rash, joint pain and arthritis-like symptoms. This disease has recently been reported in the United States, mainly as a result of importation from vacationers to areas affected by this disease. The purpose of this research was to model the disease in mice in order to identify intervention strategies that reduce disease in the hope that it will be useful in the treatment of infected humans. To do this we characterized disease in an animal model that supported virus growth and displayed important signs of disease similar to those seen in infected human patients. Mice developed swollen footpads after inoculation of virus into the footpad. Microscopic examination also revealed signs of muscle disease. The therapeutic interventions we chose to test in the mouse model included mDEF201, GP1681, an IL-6 antibody (ACT) and methotrexate. Disease was either improved, made worse, or was unaffected, depending on the treatment administered. We demonstrated activity of mDEF201 and methotrexate in improving disease in mice, while ACT showed a slight trend towards improvement and GP1681 made the disease worse. The model appeared to be suitable in identifying active compounds, but further research needs to be done to verify these benefits in a clinical setting.","abstract_html":"CHIK is an emerging viral disease that is rapidly spreading around the world and causing significant illness in infected people. This virus is spread through the bite of an infected mosquito. Symptoms of disease include high fever, rash, joint pain and arthritis-like symptoms. This disease has recently been reported in the United States, mainly as a result of importation from vacationers to areas affected by this disease. The purpose of this research was to model the disease in mice in order to identify intervention strategies that reduce disease in the hope that it will be useful in the treatment of infected humans. To do this we characterized disease in an animal model that supported virus growth and displayed important signs of disease similar to those seen in infected human patients. Mice developed swollen footpads after inoculation of virus into the footpad. Microscopic examination also revealed signs of muscle disease. The therapeutic interventions we chose to test in the mouse model included mDEF201, GP1681, an IL-6 antibody (ACT) and methotrexate. Disease was either improved, made worse, or was unaffected, depending on the treatment administered. We demonstrated activity of mDEF201 and methotrexate in improving disease in mice, while ACT showed a slight trend towards improvement and GP1681 made the disease worse. The model appeared to be suitable in identifying active compounds, but further research needs to be done to verify these benefits in a clinical setting.","abstract_has_math":false,"creators":["Dagley, Ashley L."],"institution":"Hosted by Utah State University Libraries","degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Animal, Dairy, and Veterinary Sciences","degree_department":null,"school":null,"contributors":["Justin G. Julander","Brian B. Gowen","Kerry A. Rood"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:54:31Z","subjects":["Animal Sciences","Life Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/a5bc-4fec"],"render_values":[{"text":"https://doi.org/10.26076/a5bc-4fec","href":"https://doi.org/10.26076/a5bc-4fec","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usu.edu/etd/4996","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usu.edu/etd/4996","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usu.edu%3Aetd-6034","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Justin G. Julander","Brian B. Gowen","Kerry A. Rood"]},{"key":"dc:creator","label":"Author","values":["Dagley, Ashley L."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2010-01-01T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2016-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["Hosted by Utah State University Libraries"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Animal, Dairy, and Veterinary Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Animal Sciences","Life Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usu.edu/etd/4996"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.26076/a5bc-4fec"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["CHIK is an emerging viral disease that is rapidly spreading around the world and causing significant illness in infected people. This virus is spread through the bite of an infected mosquito. Symptoms of disease include high fever, rash, joint pain and arthritis-like symptoms. This disease has recently been reported in the United States, mainly as a result of importation from vacationers to areas affected by this disease. The purpose of this research was to model the disease in mice in order to identify intervention strategies that reduce disease in the hope that it will be useful in the treatment of infected humans. To do this we characterized disease in an animal model that supported virus growth and displayed important signs of disease similar to those seen in infected human patients. Mice developed swollen footpads after inoculation of virus into the footpad. Microscopic examination also revealed signs of muscle disease. The therapeutic interventions we chose to test in the mouse model included mDEF201, GP1681, an IL-6 antibody (ACT) and methotrexate. Disease was either improved, made worse, or was unaffected, depending on the treatment administered. We demonstrated activity of mDEF201 and methotrexate in improving disease in mice, while ACT showed a slight trend towards improvement and GP1681 made the disease worse. The model appeared to be suitable in identifying active compounds, but further research needs to be done to verify these benefits in a clinical setting."]},{"key":"dc:title","label":"Title","values":["Amelioration of Chikungunya through Inhibition of the Inflammatory Response"]}]}],"canonical_facts":{"dc:contributor":["Justin G. Julander","Brian B. Gowen","Kerry A. Rood"],"dc:creator":["Dagley, Ashley L."],"dc:date.available":["2010-01-01T08:00:00Z"],"dc:date.created":["2016-05-01T07:00:00Z"],"dc:description.abstract":["CHIK is an emerging viral disease that is rapidly spreading around the world and causing significant illness in infected people. This virus is spread through the bite of an infected mosquito. Symptoms of disease include high fever, rash, joint pain and arthritis-like symptoms. This disease has recently been reported in the United States, mainly as a result of importation from vacationers to areas affected by this disease. The purpose of this research was to model the disease in mice in order to identify intervention strategies that reduce disease in the hope that it will be useful in the treatment of infected humans. To do this we characterized disease in an animal model that supported virus growth and displayed important signs of disease similar to those seen in infected human patients. Mice developed swollen footpads after inoculation of virus into the footpad. Microscopic examination also revealed signs of muscle disease. The therapeutic interventions we chose to test in the mouse model included mDEF201, GP1681, an IL-6 antibody (ACT) and methotrexate. Disease was either improved, made worse, or was unaffected, depending on the treatment administered. We demonstrated activity of mDEF201 and methotrexate in improving disease in mice, while ACT showed a slight trend towards improvement and GP1681 made the disease worse. The model appeared to be suitable in identifying active compounds, but further research needs to be done to verify these benefits in a clinical setting."],"dc:identifier":["https://digitalcommons.usu.edu/etd/4996"],"dc:identifier.doi":["https://doi.org/10.26076/a5bc-4fec"],"dc:publisher":["Hosted by Utah State University Libraries"],"dc:subject":["Animal Sciences","Life Sciences"],"dc:title":["Amelioration of Chikungunya through Inhibition of the Inflammatory Response"],"thesis:degree_discipline":["Animal, Dairy, and Veterinary Sciences"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T08:54:31Z"}